Cite
HARVARD Citation
Lapointe, M. et al. (2023). Dexrazoxane Treatments Limits Subclinical Cardiac Dysfunction in Childhood Acute Lymphoblastic Leukemia Survivors Exposed to Doxorubicin Treatments. Journal of pediatric hematology/oncology. 45 (2), pp. 70-77. [Online].